232 related articles for article (PubMed ID: 34431038)
1. Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.
Tawfik MK; Keshawy MM; Makary S
Mol Biol Rep; 2021 Sep; 48(9):6457-6470. PubMed ID: 34431038
[TBL] [Abstract][Full Text] [Related]
2. FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Ahmad SNS; Jigheh ZA; Aslani S; Panah F; Rashedi J; Mesgari Abbasi M
J Physiol Biochem; 2018 Aug; 74(3):467-478. PubMed ID: 29948786
[TBL] [Abstract][Full Text] [Related]
3. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Angiopoietin-Like Protein 2 Ameliorates Diabetic Nephropathy by Inhibiting TLR4.
Yang S; Zhang J; Wang S; Shi J; Zhao X
Cell Physiol Biochem; 2017; 43(2):685-696. PubMed ID: 28946139
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats.
Makary S; Abdo M; Hassan WA; Tawfik MK
Can J Physiol Pharmacol; 2019 Aug; 97(8):708-720. PubMed ID: 30970225
[TBL] [Abstract][Full Text] [Related]
6. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
[TBL] [Abstract][Full Text] [Related]
7. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
Zhang K; Meng X; Li D; Yang J; Kong J; Hao P; Guo T; Zhang M; Zhang Y; Zhang C
Kidney Int; 2015 Feb; 87(2):359-69. PubMed ID: 25075768
[TBL] [Abstract][Full Text] [Related]
9. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
11. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
Abdel-Rahman EM; Abadir PM; Siragy HM
Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1473-8. PubMed ID: 18799632
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats.
Alqahtani F; Mohany M; Alasmari AF; Alanazi AZ; Belali OM; Ahmed MM; Al-Rejaie SS
Int J Med Sci; 2020; 17(18):3098-3106. PubMed ID: 33173431
[No Abstract] [Full Text] [Related]
13. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.
Siragy HM; Awad A; Abadir P; Webb R
Endocrinology; 2003 Jun; 144(6):2229-33. PubMed ID: 12746279
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.
Ma Y; Xie D; Liu J; Han X; Xu H; Chen Y
Int Immunopharmacol; 2023 Feb; 115():109715. PubMed ID: 37724955
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells ameliorated kidney fibrosis by attenuating TLR4/NF-κB in diabetic rats.
Lin L; Lin H; Wang D; Bao Z; Cai H; Zhang X
Life Sci; 2020 Dec; 262():118385. PubMed ID: 32926926
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease.
Fang LN; Zhong S; Huang LJ; Lu B; Shen LW; Tang FY; Sun HP; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1114-1120. PubMed ID: 33263178
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
Morsy MA; Heeba GH; Mahmoud ME
Eur J Pharmacol; 2015 Mar; 750():90-7. PubMed ID: 25625658
[TBL] [Abstract][Full Text] [Related]
20. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
